XML 78 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details)
 3 Months Ended 6 Months Ended
May 05, 2022
USD ($)
Apr. 25, 2022
USD ($)
Nov. 11, 2020
USD ($)
$ / shares
shares
Nov. 11, 2020
$ / shares
shares
Feb. 19, 2020
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
class_of_stock
$ / shares
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
class_of_stock
$ / shares
shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
$ / shares
shares
May 17, 2021
USD ($)
$ / shares
shares
Stockholders' Equity [Line Items]                      
Number of classes of stock | class_of_stock           2   2      
Authorized capital stock (in Shares) | shares               101,000,000      
Common stock, shares authorized (in Shares) | shares           100,000,000   100,000,000   100,000,000  
Common stock par value (in Dollars per share) | $ / shares           $ 0.0001   $ 0.0001   $ 0.0001  
Preferred stock, shares authorized (in Shares) | shares           1,000,000   1,000,000      
Preferred stock par value (in Dollars per share) | $ / shares           $ 0.0001   $ 0.0001      
Agent fee percentage               6.00%      
Sale price (in Dollars per share) | $ / shares                     $ 50.00
Proceeds from common stock offering, net of offering costs               $ 1,859,685 $ 0    
Warrants outstanding, term                     10 years
Financing costs [1]           $ 0 $ 43,818,000 0 43,818,000    
Total recurring fair value measurements           673,012 12,306,000 673,012 12,306,000    
Recurring fair value measurements, gain (loss) during period           $ 4,552,464 (3,497,230) $ 9,381,936 (3,075,400)    
Purchase agreement, authorized amount                     $ 250,000,000
Grant date fair value of securities purchase agreement                     $ 12,600,000
Stonepeak                      
Stockholders' Equity [Line Items]                      
Percent of warrants issued                     90.00%
Evolve                      
Stockholders' Equity [Line Items]                      
Percent of warrants issued                     10.00%
Unit Purchase Option                      
Stockholders' Equity [Line Items]                      
Number of shares included in a unit         1.1            
Shares issued (in Dollars per share) | $ / shares         $ 100            
Exercisable units (in shares) | shares         316,250            
Options exercisable (in Dollars per share) | $ / shares         $ 11.50            
Aggregate exercise price         $ 3,636,875            
Unit Purchase Option | Minimum                      
Stockholders' Equity [Line Items]                      
Right to registration, period         5 years            
Unit Purchase Option | Maximum                      
Stockholders' Equity [Line Items]                      
Right to registration, period         7 years            
Investor                      
Stockholders' Equity [Line Items]                      
Common stock shares purchase (in Shares) | shares     1,425,000                
Purchase price per share value (in Dollars per share) | $ / shares     $ 10.00 $ 10.00              
PIPE                      
Stockholders' Equity [Line Items]                      
Sale of units (in Shares) | shares       1.9              
Sale price (in Dollars per share) | $ / shares     $ 11.50 $ 11.50              
Aggregate purchase price of common stock (in Dollars)     $ 14,250,000                
Stonepeak/Evolve Warrants - series B                      
Stockholders' Equity [Line Items]                      
Warrants outstanding, grant date fair value                     $ 12,800,000
Exercise price (in Dollars per share) | $ / shares           $ 10.00   $ 10.00      
Stonepeak/Evolve Warrants - series C                      
Stockholders' Equity [Line Items]                      
Warrants outstanding, grant date fair value                     5,600,000
Exercise price (in Dollars per share) | $ / shares           15.00   15.00      
Stonepeak/Evolve Warrants - series D                      
Stockholders' Equity [Line Items]                      
Warrants outstanding, grant date fair value                     4,800,000
Exercise price (in Dollars per share) | $ / shares           20.00   20.00      
Stonepeak/Evolve Warrants - series E                      
Stockholders' Equity [Line Items]                      
Warrants outstanding, grant date fair value                     3,800,000
Exercise price (in Dollars per share) | $ / shares           30.00   30.00      
Stonepeak/Evolve Warrants - series F                      
Stockholders' Equity [Line Items]                      
Warrants outstanding, grant date fair value                     $ 3,200,000
Exercise price (in Dollars per share) | $ / shares           40.00   $ 40.00      
Warrants                      
Stockholders' Equity [Line Items]                      
Sale of units (in Shares) | shares         5,750,000            
Stonepeak Warrants | Securities Purchase Agreement                      
Stockholders' Equity [Line Items]                      
Percent of warrants issued                     90.00%
Evolve Warrants | Securities Purchase Agreement                      
Stockholders' Equity [Line Items]                      
Percent of warrants issued                     10.00%
Stonepeak/Evolve Warrants - series B                      
Stockholders' Equity [Line Items]                      
Number of securities called by warrants (in shares) | shares                     2,000,000
Exercise price (in Dollars per share) | $ / shares                     $ 10.00
Stonepeak/Evolve Warrants - series C                      
Stockholders' Equity [Line Items]                      
Number of securities called by warrants (in shares) | shares                     1,000,000
Percent of warrants vested upon issuance                     50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                     $ 125,000,000
Percent of warrants vested upon additional capital expenditures                     50.00%
Exercise price (in Dollars per share) | $ / shares                     $ 15.00
Stonepeak/Evolve Warrants - series D                      
Stockholders' Equity [Line Items]                      
Number of securities called by warrants (in shares) | shares                     1,000,000
Percent of warrants vested upon issuance                     50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                     $ 250,000,000
Percent of warrants vested upon additional capital expenditures                     50.00%
Exercise price (in Dollars per share) | $ / shares                     $ 20.00
Stonepeak/Evolve Warrants - series E                      
Stockholders' Equity [Line Items]                      
Number of securities called by warrants (in shares) | shares                     1,000,000
Percent of warrants vested upon issuance                     50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                     $ 375,000,000
Percent of warrants vested upon additional capital expenditures                     50.00%
Exercise price (in Dollars per share) | $ / shares                     $ 30.00
Stonepeak/Evolve Warrants - series F                      
Stockholders' Equity [Line Items]                      
Number of securities called by warrants (in shares) | shares                     1,000,000
Percent of warrants vested upon issuance                     50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                     $ 500,000,000
Percent of warrants vested upon additional capital expenditures                     50.00%
Exercise price (in Dollars per share) | $ / shares                     $ 40.00
Shelf Registration                      
Stockholders' Equity [Line Items]                      
Gross proceeds from offering   $ 100,000,000                  
At The Market Offering                      
Stockholders' Equity [Line Items]                      
Gross proceeds from offering $ 25,000,000                    
Agent fee percentage 3.00%                    
Sale of units (in Shares) | shares               323,746      
Sale price (in Dollars per share) | $ / shares           $ 6.12   $ 6.12      
Proceeds from common stock offering, net of offering costs               $ 1,900,000      
IPO | Newborn                      
Stockholders' Equity [Line Items]                      
Number of warrants per unit (in Shares) | shares         1            
Percent of one share of common stock         50.00%            
Class of warrant or right, number of securities called by each warrant | shares         1            
Private Placement | Newborn                      
Stockholders' Equity [Line Items]                      
Number of warrants per unit (in Shares) | shares         1            
Private Placement | Warrants                      
Stockholders' Equity [Line Items]                      
Aggregate share purchase (in Shares) | shares         272,500            
Private Warrants                      
Stockholders' Equity [Line Items]                      
Total recurring fair value measurements           $ 182,000 1,183,000 182,000 1,183,000    
Recurring fair value measurements, gain (loss) during period           $ 251,000 $ (351,602) $ 684,000 $ 70,228    
[1] Note 2.